# Growth Hormone in the Treatment of HIV-Associated Wasting

> **NCT00489528** · PHASE3 · COMPLETED · sponsor: **EMD Serono**

## Conditions studied

- HIV Infections
- HIV Wasting Syndrome

## Interventions

- **DRUG:** Somatropin; Recombinant human growth hormone (r hGH)

## Key facts

- **NCT ID:** NCT00489528
- **Lead sponsor:** EMD Serono
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-07
- **Primary completion:** —
- **Final completion:** 2002-03
- **Target enrollment:** — (—)
- **Last updated:** 2013-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489528, "Growth Hormone in the Treatment of HIV-Associated Wasting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00489528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*